Differential molecular response in mice and human thymocytes exposed to a combined-dose radiation regime
EntityUAM. Departamento de Biología
10.1038/s41598-022-07166-8Scientific Reports 12.1 (2022): 3144
ProjectGobierno de España. SAF2015-70561-R; Comunidad de Madrid. 2017/BMD-3778/LINFOMAS
SubjectsDNA damage; Epigenetic regulation; Cell cycle; Thymocyte; Gene expression regulation; Biología y Biomedicina / Biología
Rights© The Author(s) 2022
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.
In the quest for more effective radiation treatment options that can improve both cell killing and healthy tissue recovery, combined radiation therapies are lately in the spotlight. The molecular response to a combined radiation regime where exposure to an initial low dose (priming dose) of ionizing radiation is administered prior to a subsequent higher radiation dose (challenging dose) after a given latency period have not been thoroughly explored. In this study we report on the differential response to either a combined radiation regime or a single challenging dose both in mouse in vivo and in human ex vivo thymocytes. A differential cell cycle response including an increase in the subG1 fraction on cells exposed to the combined regime was found. Together with this, a differential protein expression profiling in several pathways including cell cycle control (ATM, TP53, p21CDKN1A), damage response (γH2AX) and cell death pathways such as apoptosis (Cleaved Caspase-3, PARP1, PKCδ and H3T45ph) and ferroptosis (xCT/GPX4) was demonstrated. This study also shows the epigenetic regulation following a combined regime that alters the expression of chromatin modifiers such as DNMTs (DNMT1, DNMT2, DNMT3A, DNMT3B, DNMT3L) and glycosylases (MBD4 and TDG). Furthermore, a study of the underlying cellular status six hours after the priming dose alone showed evidence of retained modifications on the molecular and epigenetic pathways suggesting that the priming dose infers a “radiation awareness phenotype” to the thymocytes, a sensitization key to the differential response seen after the second hit with the challenging dose. These data suggest that combined-dose radiation regimes could be more efficient at making cells respond to radiation and it would be interesting to further investigate how can these schemes be of use to potential new radiation therapies
Google Scholar:López Nieva, María Pilar - González Vasconcellos, Iria - González Sánchez, Laura - Cobos Fernández, María Ángeles - Ruiz García, Sara - Sánchez Pérez, Raúl - Aroca Peinado, Ángel - Fernández Piqueras, José - Santos Hernández, Fco. Javier
This item appears in the following Collection(s)
Showing items related by title, author, creator and subject.
RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas López-Nieva, Pilar; Fernández-Navarro, Pablo; Vaquero-Lorenzo, Concepción; Villa-Morales, María; Graña-Castro, Osvaldo; Cobos Fernández, María Ángeles; López-Lorenzo, José Luis; Llamas Sillero, Pilar; González-Sánchez, Laura; Sastre, Isabel; Pollán Santamaría, Marina Anunciación; Malumbres, Marcos; Santos, Javier; Fernández Piqueras, José
Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project Valero-Jaimes, Jesús A.; López-González, Ruth; Martín-Martínez, María A.; García-Gómez, Carmen; Sánchez-Alonso, Fernando; Sánchez-Costa, Jesús T.; González-Juanatey, Carlos; Revuelta-Evrad, Eva; Díaz-Torné, César; Fernández-Espartero, Cruz; Pérez-García, Carolina; Torrente-Segarra, Vicenç; Sánchez-Nievas, Ginés; Pérez-Sandoval, Trinidad; Font-Ugalde, Pilar; García-Vivar, María L.; Aurrecoechea, Elena; Maiz-Alonso, Olga; Valls-García, Ramón; Miranda-Filloy, José A.; Llorca, Javier; Castañeda Sanz, Santos; Gonzalez-Gay, Miguel A.; CARMA Study Group